Anchiano Therapeutics Ltd ADR (ANCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANCN | AMGN | BMY | GILD | MRNA |
| Company | Anchiano Therapeutics Ltd ADR | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 81.60 | 265.72 | 44.68 | 65.50 | 106.18 |
| High | 131.20 | 271.68 | 45.37 | 66.35 | 108.19 |
| Low | 73.60 | 265.72 | 44.34 | 64.63 | 105.25 |
| Last | 75.36 | 269.98 | 44.85 | 65.42 | 107.97 |
| Change | +3.84 | +0.60 | +0.15 | +0.15 | +1.79 |
| % Change | +5.37% | +0.22% | +0.34% | +0.23% | +1.69% |
| Volume | 1,564,843 | 2,436,900 | 21,281,927 | 12,381,100 | 2,246,800 |
| 20-Day Average Volume | 4,785,015 | 2,156,940 | 13,205,330 | 7,062,325 | 3,052,585 |
| Previous Close | 71.52 | 269.38 | 44.70 | 65.27 | 106.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.07 | 269.99 | 49.47 | 68.29 | 105.07 |
| 20-Day Raw Stochastic | 37.68% | 40.03% | 5.16% | 9.20% | 58.07% |
| 20-Day Relative Strength | 56.58% | 45.47% | 29.15% | 29.21% | 54.97% |
| Weighted Alpha | +284.79 | +9.45 | -34.43 | -23.49 | -9.40 |
| Today's Opinion | 96% Buy | 72% Sell | 88% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 96% Buy | 72% Sell | 88% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 8% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.92% since 03/09/21 | +0.39% since 04/19/24 | -8.34% since 04/19/24 | -2.01% since 04/19/24 | +6.47% since 04/19/24 |
| Low | 4.03 on 03/10/21 | 265.72 on 04/26/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 99.30 on 04/22/24 |
| High | 8.20 on 03/16/21 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.90 on 04/25/24 | 111.29 on 04/24/24 |
| 1-Month | |||||
| %Chg | -3.68% since 02/16/21 | -4.18% since 03/26/24 | -14.65% since 03/26/24 | -9.65% since 03/26/24 | +0.52% since 03/26/24 |
| Low | 2.60 on 03/04/21 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 97.00 on 04/03/24 |
| High | 8.20 on 03/16/21 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | +79.77% since 12/16/20 | -13.40% since 01/26/24 | -9.76% since 01/26/24 | -17.73% since 01/26/24 | +6.05% since 01/26/24 |
| Low | 1.65 on 01/04/21 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 84.06 on 02/13/24 |
| High | 10.55 on 02/10/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 80.00 on 01/29/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +344.34% since 09/16/20 | +0.10% since 10/26/23 | -15.33% since 10/26/23 | -16.66% since 10/26/23 | +42.10% since 10/26/23 |
| Low | 0.91 on 10/22/20 | 249.70 on 10/31/23 | 44.34 on 04/26/24 | 64.63 on 04/26/24 | 62.55 on 11/02/23 |
| High | 10.55 on 02/10/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,948 | 144,488,960 | 90,596,128 | 81,266,176 | 40,654,200 |
| Shares Outstanding, K | 7,420 | 536,376 | 2,026,759 | 1,245,077 | 382,880 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -11,610,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -2,140,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 0.95 | 0.58 | 0.39 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/06/21 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 6.51 | 9.98 | 0.00 |